Case-Based Roundtable Meeting Spotlight September 2021:Hematologic Malignancies | Case-Based Roundtable Meetings Spotlight

Usmani Considers Possible Treatments for a Patient With Relapsed/Refractory Multiple Myeloma

September 14, 2021

Clinical Articles

Two year after being diagnosed with stage II multiple myeloma, a 78-year-old female patient was still receiving daratumumab plus lenalidomide maintenance and presented with mild fatigue during a routine follow-up.